<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

Biotech company partners with National Jewish Health to test potential Covid-19 therapy

Default sub title

minute read

For National Jewish Health’s part, joining in this double-blind, placebocontrolled study meant addressing a major need of Covid-19. “There
aren’t really therapeutic options for patients with Covid-19,” said
Michael Wechsler, a pulmonologist at National Jewish Health [and
professor of medicine at CU School of Medicine] who is involved with
the study.

Topics: Press Coverage

Related Stories